NYSE:BIOA

Bioamber Stock Insider Trading

etoro logo Buy BIOA
*Your capital is at risk
$22.32
+0.85 (+3.96%)
At Close: Jun 23, 2026

BioAmber Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -45.38. In total, the insiders bought 6.17M and sold 378.12K BIOA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-45.38
Buy 6.17M shares
Sell 378.12K shares
89% Buy Activity
Moderate Negative Correlation
Buy Signal Low Confidence
Feb 17, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -45.38.
  • Confidence increased due to high data reliability score of 100.
  • Supported by overwhelming buy-side pressure (89% buys).

Historical Insider Trades

Date Type Person Role Amount
Jun 10, 2026
Buy
Stock Option (Right to Buy)
A-Award
Garnier Jean Pierre
Director
Director 22 000
Value: $340.6K
Jun 10, 2026
Buy
Stock Option (Right to Buy)
A-Award
Davidson Michael H.
Director
Director 22 000
Value: $340.6K
Jun 10, 2026
Buy
Stock Option (Right to Buy)
A-Award
Enright Patrick G
Director
Director 22 000
Value: $340.6K
Jun 10, 2026
Buy
Stock Option (Right to Buy)
A-Award
Healy James
Director
Director 22 000
Value: $340.6K
Jun 10, 2026
Buy
Stock Option (Right to Buy)
A-Award
Hemrajani Rekha
Director
Director 22 000
Value: $340.6K
Jun 10, 2026
Buy
Stock Option (Right to Buy)
A-Award
Pande Vijay Satyanand
Director
Director 22 000
Value: $340.6K
Apr 23, 2026
Buy
Common Stock
M-Exempt
Goldstein Dov A Md
Chief Financial Officer
C-Suite Officer 3 542
Value: $15.5K
Apr 23, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Goldstein Dov A Md
Chief Financial Officer
C-Suite Officer 3 542
Value: $15.5K
Apr 01, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Rubin Paul D
Chief Medical Officer
Officer 3 383
Value: $22.2K
Apr 01, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Rubin Paul D
Chief Medical Officer
Officer 5 437
Value: $22.3K
Apr 01, 2026
Sell
Common Stock
S-Sale
Rubin Paul D
Chief Medical Officer
Officer 8 820
Value: $157.1K
Apr 01, 2026
Buy
Common Stock
M-Exempt
Rubin Paul D
Chief Medical Officer
Officer 5 437
Value: $22.3K
Apr 01, 2026
Buy
Common Stock
M-Exempt
Rubin Paul D
Chief Medical Officer
Officer 3 383
Value: $22.2K
Mar 02, 2026
Sell
Common Stock
S-Sale
Rubin Paul D
Chief Medical Officer
Officer 7 433
Value: $150.9K
Mar 02, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Rubin Paul D
Chief Medical Officer
Officer 2 000
Value: $13.1K
Mar 02, 2026
Buy
Common Stock
M-Exempt
Rubin Paul D
Chief Medical Officer
Officer 5 433
Value: $22.3K
Mar 02, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Rubin Paul D
Chief Medical Officer
Officer 5 433
Value: $22.3K
Mar 02, 2026
Buy
Common Stock
M-Exempt
Rubin Paul D
Chief Medical Officer
Officer 2 000
Value: $13.1K
Mar 01, 2026
Buy
Common Stock
M-Exempt
Goldstein Dov A Md
Chief Financial Officer
C-Suite Officer 3 542
Value: $15.5K
Mar 01, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Goldstein Dov A Md
Chief Financial Officer
C-Suite Officer 3 542
Value: $15.5K
Feb 17, 2026
Buy
Stock Option (Right to Buy)
A-Award
Barton Shane
Principal Accounting Officer
Officer 45 000
Value: $883.4K
Feb 17, 2026
Buy
Stock Option (Right to Buy)
A-Award
Fortney Kristen
Chief Executive Officer
CEO / President 330 000
Value: $6.48M
Feb 17, 2026
Buy
Stock Option (Right to Buy)
A-Award
Goldstein Dov A Md
Chief Financial Officer
C-Suite Officer 110 000
Value: $2.16M
Feb 17, 2026
Buy
Stock Option (Right to Buy)
A-Award
Morgen Eric
Chief Operating Officer
C-Suite Officer 12 500
Value: $245.4K
Feb 17, 2026
Buy
Stock Option (Right to Buy)
A-Award
Morgen Eric
Chief Operating Officer
C-Suite Officer 110 000
Value: $2.16M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.39% Jun 10
E
ETD
$20.67
4.79% Jun 05
EAT
$140.46
16.94% Jun 05
TPR
$140.47
7.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE